Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001860782-24-000081
Filing Date
2024-05-09
Accepted
2024-05-09 16:03:41
Documents
81
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tsvt-20240331.htm   iXBRL 10-Q 1011636
2 EX-10.1 projectfirefox-aparedacted.htm EX-10.1 593088
3 EX-31.1 tsvt-q1202410xqexhibit311cb.htm EX-31.1 8935
4 EX-31.2 tsvt-q1202410xqexhibit312ve.htm EX-31.2 9022
5 EX-32.1 tsvt-q1202410xqexhibit321.htm EX-32.1 5769
  Complete submission text file 0001860782-24-000081.txt   7244271

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tsvt-20240331.xsd EX-101.SCH 61690
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tsvt-20240331_cal.xml EX-101.CAL 71044
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tsvt-20240331_def.xml EX-101.DEF 287994
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tsvt-20240331_lab.xml EX-101.LAB 639652
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tsvt-20240331_pre.xml EX-101.PRE 461313
84 EXTRACTED XBRL INSTANCE DOCUMENT tsvt-20240331_htm.xml XML 837787
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

EIN.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40791 | Film No.: 24930354
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)